Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.
Also called NCT02132026
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 152 participants
- Registry
-
NCT02132026
-
- Other papers using this trial's data
- Artificial Intelligence-Enabled Echocardiography as a Surrogate for Multimodality Aortic Stenosis Imaging: Post Hoc Analysis of a Clinical Trial
- Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial
- Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial
- Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02132026. Randomized; quadruple masking; primary purpose treatment. Start 2014-11-12 (actual); primary completion 2019-11-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
- Acronym
- SALTIRE II
- Condition
- Calcific Aortic Stenosis
- Intervention (Drug)
- Denosumab
- Intervention (Drug)
- Alendronic Acid
- Intervention (Drug)
- Denosumab Placebo
- Intervention (Drug)
- Alendronic Acid Placebo
- Lead sponsor
- University of Edinburgh
- Collaborator
- British Heart Foundation
- Collaborator
- NHS Lothian
Record details
- Record id
cardio:ct-nct02132026- Content hash
42d048efe7f3ac090e271abe8dfed362b14d00f4ef7c1e30987b3e7fd221dbba